Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3Genitourinary 1CNS 1Breast 1

Conditions

Skin Neoplasms 2Keratosis, Actinic 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 193aldesleukin 145Interleukin-2 109fludarabine phosphate 106Temozolomide 83Dacarbazine 81fludarabine 80Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Carboplatin 48Magnetic Resonance Spectroscopy 47Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42atezolizumab 41Specimen Handling 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Niacin × Dermatologic × Clear all
NCT05702398 2026-03-20

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Rhode Island Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Dermatologic

Skin Neoplasms

NCT04843553 2021-04-22

NICE

Rhode Island Hospital

Phase EARLY_PHASE1 Completed
30 enrolled
Dermatologic

Keratosis, Actinic

NCT00619060 2016-03-10

Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers

University of Arizona

Phase 1 Completed
22 enrolled 5 charts
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡